Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Knight

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
Annals of the Rheumatic Diseases|June 7, 2025
Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trialD Ware Branch, Mimi Y Kim, Marta M Guerra, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndromeSrilakshmi Yalavarthi, Travis J Gould, Ashish N Rao, et al.
Clinical Immunology (Orlando, Fla.)|August 1, 2023
Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular trapsKatarína Kmeťová, Elena Lonina, Srilakshmi Yalavarthi, et al.
ACR Open Rheumatology|December 3, 2022
Predictors and Interrelationship of Patient-Reported Outcomes in Antiphospholipid Syndrome: A Cross-Sectional StudyJulia K Weiner, Tristin Smith, Claire K Hoy, et al.
Mbio|December 8, 2022
The IRE1α-XBP1 Signaling Axis Promotes Glycolytic Reprogramming in Response to Inflammatory StimuliBevin C English, Hannah P Savage, Scott P Mahan, et al.
Journal of Leukocyte Biology|September 2, 2020
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, et al.
Science Advances|October 25, 2023
Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic miceChao Liu, Srilakshmi Yalavarthi, Ajay Tambralli, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, et al.
Rheumatology (Oxford, England)|March 24, 2022
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APSHongjiang Liu, Chun Li, Hui Shi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2025
Molecular stratification of antiphospholipid syndrome through integrative analysis of the whole-blood RNA transcriptomeAmala Ambati, Feiyang Ma, Katarina Kmetova, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Annals of the Rheumatic Diseases|June 7, 2025
Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trialD Ware Branch, Mimi Y Kim, Marta M Guerra, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndromeSrilakshmi Yalavarthi, Travis J Gould, Ashish N Rao, et al.
Clinical Immunology (Orlando, Fla.)|August 1, 2023
Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular trapsKatarína Kmeťová, Elena Lonina, Srilakshmi Yalavarthi, et al.
ACR Open Rheumatology|December 3, 2022
Predictors and Interrelationship of Patient-Reported Outcomes in Antiphospholipid Syndrome: A Cross-Sectional StudyJulia K Weiner, Tristin Smith, Claire K Hoy, et al.
Mbio|December 8, 2022
The IRE1α-XBP1 Signaling Axis Promotes Glycolytic Reprogramming in Response to Inflammatory StimuliBevin C English, Hannah P Savage, Scott P Mahan, et al.
Journal of Leukocyte Biology|September 2, 2020
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, et al.
Science Advances|October 25, 2023
Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic miceChao Liu, Srilakshmi Yalavarthi, Ajay Tambralli, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, et al.
Rheumatology (Oxford, England)|March 24, 2022
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APSHongjiang Liu, Chun Li, Hui Shi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2025
Molecular stratification of antiphospholipid syndrome through integrative analysis of the whole-blood RNA transcriptomeAmala Ambati, Feiyang Ma, Katarina Kmetova, et al.
Pageof 17